Giorgio Gandaglia

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 452 publications

Re: Alexander D. Sherry, Cara Haymaker, Shuqi Wang, et al. Addition of Metastasis-directed Therapy to Standard of Care for Oligometastatic Disease: Primary Aggregated Analysis of All Baskets from the Phase II Randomized EXTEND Trial. J Clin Oncol. In press. http://dx.doi.org/10.1200/JCO-25-02856.

Re: Alexander D. Sherry, Cara Haymaker, Shuqi Wang, et al. Addition of Metastasis-directed Therapy to Standard of Care for Oligometastatic Disease: Primary Aggregated Analysis of All Baskets from the Phase II Randomized EXTEND Trial. J Clin Oncol. In press. http://dx.doi.org/10.1200/JCO-25-02856.

Journal: European urology
Published: August 13, 2026

Focal Therapy for Prostate Cancer.

Focal Therapy for Prostate Cancer.

Journal: JAMA
Published: August 13, 2026

Patient selection for prostate cancer focal therapy guided by mpMRI-PSMA PET concordance and pathology review.

Patient selection for prostate cancer focal therapy guided by mpMRI-PSMA PET concordance and pathology review.

Journal: BJU international
Published: August 12, 2026

Re: Chernysheva D, Di Bello F, Avesani G et al. ProBIOPSY: A Multidisciplinary International Consensus on Standards for Prostate Biopsy. Eur Urol 2026; S0302-2838(26)02233-5.

Re: Chernysheva D, Di Bello F, Avesani G et al. ProBIOPSY: A Multidisciplinary International Consensus on Standards for Prostate Biopsy. Eur Urol 2026; S0302-2838(26)02233-5.

Journal: European urology
Published: July 24, 2026

Re: Robert M. Meier, Nima Aghdam, Alan C. Beckman, et al. 10-yr Survival and Toxicity Outcomes of Stereotactic Body Radiotherapy for Prostate Cancer: A Nonrandomized Clinical Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.04.029.

Re: Robert M. Meier, Nima Aghdam, Alan C. Beckman, et al. 10-yr Survival and Toxicity Outcomes of Stereotactic Body Radiotherapy for Prostate Cancer: A Nonrandomized Clinical Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.04.029.

Journal: European urology
Published: July 20, 2026

Impact of prostate mpMRI quality on diagnostic accuracy in prostate cancer: a prospective study.

Impact of prostate mpMRI quality on diagnostic accuracy in prostate cancer: a prospective study.

Journal: BJU international
Published: July 08, 2026

Surgical Management of PSMA PET-Positive Lymph Nodes in Prostate Cancer.

Surgical Management of PSMA PET-Positive Lymph Nodes in Prostate Cancer.

Journal: Current urology reports
Published: July 06, 2026

ASO Author Reflections: Quantifying the Unseen: Years of Life Lost as a Patient-Centered Metric in Advanced Bladder Cancer.

ASO Author Reflections: Quantifying the Unseen: Years of Life Lost as a Patient-Centered Metric in Advanced Bladder Cancer.

Journal: Annals of surgical oncology
Published: June 08, 2026

PROTEUS Trial the Day After: Practice Changing or Premature Escalation?

PROTEUS Trial the Day After: Practice Changing or Premature Escalation?

Journal: European urology oncology
Published: June 03, 2026

Re: Hormone Therapy Use and Duration with Postoperative Radiotherapy for Recurrent Prostate Cancer: an Individual Patient Data Meta-analysis.

Re: Hormone Therapy Use and Duration with Postoperative Radiotherapy for Recurrent Prostate Cancer: an Individual Patient Data Meta-analysis.

Journal: European urology
Published: May 23, 2026

Real-World Treatment Patterns and Predictors of Treatment Allocation in Metastatic Non-Clear Cell Renal Cell Carcinoma: A National Cancer Database Analysis.

Real-World Treatment Patterns and Predictors of Treatment Allocation in Metastatic Non-Clear Cell Renal Cell Carcinoma: A National Cancer Database Analysis.

Journal: Clinical genitourinary cancer
Published: May 19, 2026

PSMA Radio-guided Surgery to Identify Lymph Node Metastases in Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Phase 2 Prospective Study.

PSMA Radio-guided Surgery to Identify Lymph Node Metastases in Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Phase 2 Prospective Study.

Journal: European urology
Published: April 30, 2026
Showing 1-12 of 452

Last Updated: 09/26/2026